Table of Contents Table of Contents
Previous Page  147 / 398 Next Page
Information
Show Menu
Previous Page 147 / 398 Next Page
Page Background

142

matched control samples. Retrieval of clinical data and patients

followed a mean period of 32.1 months.

Findings:

After a mean follow-up period of 32.1 months (range,

1–102 months), recurrence was diagnosed as end point for seven

patients, with 43.75% (7/16) of cumulative recurrence rate. Com-

paring to gender and age matched controls, patients showed strong

in situ

expressions of IL-21 and pERK1/2 respectively (

P

< 0.05).

Patients with strong IL-21 staining intensity and overexpression

of pERK1/2 had a lower recurrence rate than those with moderate

staining intensity (

P

= 0.049 and

P

= 0.019, respectively). How-

ever, differences were not statistically significant by gender, age,

eosinophils, location, multiplicity, laterality, size, duration and pri-

mary outbreak. pERK1/2 was the independent prognostic factor

(

P

= 0.020), while age, gender, eosinophils, multiplicity, laterality,

size, duration, primary outbreak and expression of IL-21 were not.

Conclusion:

Our data suggested that IL-21/pERK1/2 pathway is

activated in KD and pERK1/2 might be considered as a potential

prognostic indicator in KD.

http://dx.doi.org/10.1016/j.ijom.2017.02.490

Ameloblastoma: a review of biological profile and

management over a 17-year period

A. Chiamwaroseth

∗

, C. Chinkrua, W. Powcharoen

Chiang Mai University, Chiang Mai, Thailand

Background:

Ameloblastoma is one of the most common benign

odontogenic tumour of the maxillofacial region. Treatment modal-

ities become critical and controversy.

Objective:

To discuss about the clinical, imaging, treatment and

prognostic characteristics of these tumours in patients who were

diagnosed and treated at Faculty of Dentistry, Chiang Mai Uni-

versity.

Methods:

This was a retrospective study and comprised of patients

who presented with ameloblastoma at the Department of Oral and

Maxillofacial Surgery, Faculty of Dentistry, Chiang Mai Univer-

sity between 1999 and 2016. This study analysed clinical, imaging,

treatment and prognostic characteristics of these tumours.

Findings:

36 patients (87.80%) were adult and five patients

(12.20%) were young. The mean age was 38.25 years. The

distribution ratio of male and female was 1.55:1. It mostly

occurred in body-ramus areas (95.12%). Radiographic appearance

showed multilocular radiolucency (78.05%). Plexiform type was

predominated histological finding (41.46%). The management

were resection (65.85%) and conservative treatment (34.15%).

Recurrence was found in six patients (14.63%) who received con-

servative treatment. One of them was atypical multiple episodes

of soft tissue recurrence.

Conclusions:

In our centre, solid multicystic ameloblastoma is

most common. To prevent the recurrence, treatment should be

resection involved one anatomical barrier. In young patients, sur-

geon should concern about growth and psychological factor. When

conservative treatment was done, patient compliance and long-

term follow-up treatment are necessary.

http://dx.doi.org/10.1016/j.ijom.2017.02.491

Association between the maxillary sinus mucosal thickening

and periapical lesions using cone-beam computed

tomography

K. Deniz

∗

, A. Aydogdu.

Baskent University Istanbul Research Hospital, Departments of

Oral and Maxillofacial Surgery and Periodontology, Turkey

Objective:

Odontogenic infections are a common cause of maxil-

lary sinusitis. This retrospective cross-sectional study evaluated

the association between periapical lesions and sinus mucosal

thickening using cone-beam computed tomography (CBCT)

imaging.

Methods:

CBCT images of 696 maxillary sinuses were inspected

retrospectively for the presence of periapical lesions, relation of

the periapical lesions to the sinus floor and periodontal bone loss

in posterior maxillary teeth and associated sinus mucosal thick-

ening. Thickening >2 mm was considered pathological and was

categorised by degree (2–5 mm, 5–10 mm, >10 mm) and type (flat

or polypoid). Relations of the periapical lesion and sinus floor

were; a space between the lesion and sinus floor, the lesion was in

contact with the sinus floor and the lesion entered the sinus floor.

Data were analysed using Chi squared tests.

Results:

Mucosal thickening >2 mm was observed in 522 (75%)

of the sinuses. Mucosal thickening that are >2 mm was more fre-

quently found in relation to teeth with periapical lesions (94.3%)

Significant association was found between mucosal thickening

and periapical lesions. Polypoid type thickening was frequently

observed when the periapical lesion is in contact with (50%) or

entered the sinus floor (46.6%). Flat-type thickening was mostly

observed when there is a space between the periapical lesion and

sinus floor (43.4%) or the lesion is in contact with the sinus floor

(47.8%).

Conclusion:

Teeth with periapical lesions were 16.5 times more

likely to be associated with mucosal thickening than those with-

out. The anatomic relationship between periapical lesions and

maxillary sinus floor could affect the mucosal sinus development.

http://dx.doi.org/10.1016/j.ijom.2017.02.492

Methotrexate-related lymphoproliferative disorder in

patients with osteonecrosis of the jaw

K. Furudate

∗

, H. Sato, W. Kobayashi

Department of Oral and Maxillofacial Surgery, Tsugaru

General Hospital, Goshogawara, Japan

Patients who are immunodeficient or immunosuppressed are

at risk of developing lymphoproliferative disorder (LPD).

Methotrexate (MTX) is an iatrogenic cause of LPD. However,

the occurrence of MTX-related LPD causing osteonecrosis of the

jaw (ONJ) has rarely been reported.

We report a series of three cases of MTX-related LPD in

patients with longstanding rheumatoid arthritis who presented

with ONJ. A 74-year-old man with rheumatoid arthritis (RA)

had received treatment with MTX for seven years before present-

ing with ONJ and submental lymphadenopathy following dental

extraction. The second patient was a 79-year-old woman who had

been treated for 21 years with MTX and who presented with ONJ.

The third patient in our series was a 67-year-old man who had been

treated withMTX for more than 15 years. In all three cases, biopsy,